Success Metrics

Clinical Success Rate
88.2%

Based on 60 completed trials

Completion Rate
88%(60/68)
Active Trials
15(14%)
Results Posted
43%(26 trials)
Terminated
8(7%)

Phase Distribution

Ph phase_1
11
10%
Ph phase_3
23
21%
Ph phase_2
12
11%
Ph early_phase_1
3
3%
Ph phase_4
34
32%
Ph not_applicable
19
18%

Phase Distribution

14

Early Stage

12

Mid Stage

57

Late Stage

Phase Distribution102 total trials
Early Phase 1First-in-human
3(2.9%)
Phase 1Safety & dosage
11(10.8%)
Phase 2Efficacy & side effects
12(11.8%)
Phase 3Large-scale testing
23(22.5%)
Phase 4Post-market surveillance
34(33.3%)
N/ANon-phased studies
19(18.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.5%

60 of 71 finished

Non-Completion Rate

15.5%

11 ended early

Currently Active

15

trials recruiting

Total Trials

107

all time

Status Distribution
Active(16)
Completed(60)
Terminated(11)
Other(20)

Detailed Status

Completed60
unknown19
Recruiting14
Terminated8
Withdrawn3
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
107
Active
15
Success Rate
88.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (2.9%)
Phase 111 (10.8%)
Phase 212 (11.8%)
Phase 323 (22.5%)
Phase 434 (33.3%)
N/A19 (18.6%)

Trials by Status

recruiting1413%
terminated87%
suspended11%
completed6056%
not_yet_recruiting11%
active_not_recruiting11%
withdrawn33%
unknown1918%

Recent Activity

Clinical Trials (107)

Showing 20 of 107 trialsScroll for more
NCT06966804Phase 3

Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms

Recruiting
NCT07715448Phase 4

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

Completed
NCT07654413Phase 4

Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia

Recruiting
NCT07310797Phase 4

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

Recruiting
NCT07623876Phase 2

Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS

Recruiting
NCT07617909Phase 2

L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones

Recruiting
NCT07562282Not Applicable

Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg

Recruiting
NCT06257576Phase 3

Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter

Completed
NCT04597372Phase 2

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Recruiting
NCT07467343Phase 4

Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial

Not Yet Recruiting
NCT05657990Early Phase 1

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Recruiting
NCT07274228

Tamsulosin and the Risk of Serious Adverse Events

Completed
NCT02483793Not Applicable

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Withdrawn
NCT06568718Not Applicable

Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Completed
NCT07307261Not Applicable

Evaluation of Mirabegron Versus Tamsulosin or Their Combination in Treatment of Lower Urinary Tract Symptoms

Completed
NCT05753670Phase 3

Effect of Preoperative Tamsulosin on Postoperative Urinary Retention

Completed
NCT07169773Not Applicable

Comparative Study Between Rezum and Tamsulosin

Completed
NCT03808155Phase 4

Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty

Completed
NCT05415748Phase 4

Deprescribing Tamsulosin in Older Men

Completed
NCT07114848Phase 4

Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
107